Surviving the Pediatric Intensive Care Unit (PICU)

NCT ID: NCT06812130

Last Updated: 2025-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

404 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-11

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Improvement in pediatric intensive care unit (PICU) supportive care has led to improvement in clinical outcomes and decreased mortality in pediatric critical illness. However, PICU survivors are at risk of long-term health sequalae. Given the increased recognition of physical, cognitive, and psychological sequelae in PICU survivors, the concept of post-intensive care syndrome-pediatrics (PICS-p) has been proposed. Besides the PICU patient/survivor, the PICS-p framework also highlights the impacts of a child's critical illness has on the family. The impact of a PICU admission extends beyond the patient and parents, potentially affecting healthy siblings who are navigating their own developmental challenges. Healthy siblings may face emotional distress, increased responsibilities, and disruptions in their daily routines, all of which can contribute to long-term negative outcomes if unaddressed. Thus, this study consists of two cohorts to understand the long-term physical, cognitive, and psychological outcomes in PICU survivors and their families, and the short-term impacts on siblings of critically ill children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of Helping to Optimize Patients' Experiences (HOPE) after Pediatric Critical Illness Cohort Study are:

1. \[Primary\] To characterize physical and cognitive health outcomes of PICU survivors.
2. \[Primary\] To investigate subgroups of critically ill children who have poor medium-term physical and cognitive health outcomes.
3. \[Primary\] To elucidate risk factors for poor physical and cognitive health outcomes in PICU survivors.
4. \[Exploratory\] To investigate the impact of physical and cognitive health of PICU survivors on overall family health.

The objectives of Singapore Health outcomes After Critical illness in Kids - Siblings (SHACK-S): Health Outcomes and Experiences of Healthy Siblings in the first 6 months after PICU discharge are:

1. \[Primary\] To describe and compare quality-of-life in healthy siblings at 1, 3 and 6 months after PICU discharge.
2. \[Primary\] To explore the experiences and support needs of healthy siblings 6 months after PICU discharge of a critically ill child.
3. \[Secondary\] To examine the experiences of recovery trajectory of healthy siblings.

Thus, HOPE cohort will provide information and insight regarding which groups of PICU patients and associated PICU therapies are associated with the highest risk for poor survivorship. The conduct of this study will also allow us to identify the challenges and find appropriate solutions in performing a cohort study with an emphasis on patient-reported outcomes (e.g., functional status, cognition and quality of life). Concurrently, the SHACK-S cohort will provide insights to understand the impacts of PICU admission on siblings and their recovery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Intensive Care Syndrome (PICS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HOPE Cohort (PICU Survivors)

Helping to Optimize Patients' Experiences (HOPE) after Pediatric Critical Illness Cohort Study \[Sample Size: 240 participants\]

This is a non-interventional study.

Intervention Type OTHER

This is a non-interventional study.

SHACK-S Cohort (Siblings of PICU Survivors)

Singapore Health outcomes After Critical illness in Kids - Siblings (SHACK-S): Experiences and Health Outcomes of Siblings in the first 6 months after PICU discharge of a critically ill child. \[Sample Size (Quantitative): 164 participants; Sample Size (Qualitative): 20 participants\]

This is a non-interventional study.

Intervention Type OTHER

This is a non-interventional study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

This is a non-interventional study.

This is a non-interventional study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\[HOPE Cohort\]

1. Between 28 days - 16 years of age at PICU admission
2. Have an expected PICU stay \> 48 hours

\[SHACK-S Cohort\]

1. Healthy children (aged 4 -16 years old) with critically ill sibling between 28 days - 16 years of age at PICU admission
2. Has a critically ill sibling who has an expected PICU stay \> 48 hours
3. Lives in the same household as the critically ill sibling and parents prior to admission

Exclusion Criteria

\[HOPE Cohort\]

1. Do-Not-Resuscitate status
2. Lack of informed consent
3. Prior enrolment in this study

\[SHACK-S Cohort\]

1. Children of critically ill sibling with Do-Not-Resuscitate status
2. Children with condition listed on paediatric Complex Chronic Conditions (CCC) system Version 3.0 or with neurocognitive/neurodevelopmental delays or disorders
3. Previous admission to PICU
4. Lack of informed consent
5. Prior enrolment in this study
Minimum Eligible Age

28 Days

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National University Hospital, Singapore

OTHER

Sponsor Role collaborator

Duke-NUS Graduate Medical School

OTHER

Sponsor Role collaborator

KK Women's and Children's Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jan Hau Lee

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

A/Prof Lee Jan Hau, MBBS, MRCPCH, MCI

Role: PRINCIPAL_INVESTIGATOR

KK Women's and Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National University Singapore

Singapore, Singapore, Singapore

Site Status NOT_YET_RECRUITING

KK Women's and Children's Hospital

Singapore, Singapore, Singapore

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eric Jia Yong Ong, BSc (Hons)

Role: CONTACT

+65 62255554

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr Fan Lijia, MBBS, MMed, MRCPCH

Role: primary

Eric Jia Yong Ong, BSc (Hons)

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ECOS Ref: 2024-3978

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PICU Patient Diary
NCT03777527 UNKNOWN
Oxy-PICU Neurodevelopmental Follow-up Study
NCT06734715 NOT_YET_RECRUITING
LongVentKids Study
NCT04112459 UNKNOWN